Amgen Apr 20, 2026 Zurcher Kantonalbank Zurich Cantonalbank Buys 55,333 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Apr 16, 2026 Federal Circuit Distinguishes Amgen in Reversal of Invalidation of Teva Headache Treatment Patents - IPWatchdog.com
BioPharma Dive Apr 6, 2026 Under-the-skin Tepezza comparable to infused version in key study, Amgen says
Endpoints News Apr 6, 2026 Amgen seeks to buoy Tepezza with injectable data in face of incoming competition
FierceBiotech Feb 4, 2026 Amgen advances toward lupus redemption while gastric cancer candidate struggles
FierceBiotech Jan 30, 2026 Amgen jilts Kyowa, exiting $400M autoimmune pact after running vast pivotal program
FierceBiotech Jan 13, 2026 JPM26, Day 2: Amgen touts MariTide's showing in exploratory weight loss maintenance study
Endpoints News Dec 12, 2025 FDA broadens label for Amgen's Uplizna as it enters rare disease competition
FierceBiotech Dec 11, 2025 Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx